Pacific Biosciences of California, Inc. (PACB) Covered Calls

Pacific Biosciences of California, Inc. covered calls Pacific Bio sciences of California Inc is engaged in design, development and commercialization of innovative tools for biological research. The Company's products include the SMRT Cell, Phospholinked nucleotides, the PacBio RS.

You can sell covered calls on Pacific Biosciences of California, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for PACB (prices last updated Fri 4:16 PM ET):

Pacific Biosciences of California, Inc. (PACB) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.47 +0.09 1.43 1.47 7.9M - 0.4
Covered Calls For Pacific Biosciences of California, Inc. (PACB)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 1 0.00 1.47 -32.0% -530.9%
Jun 21 1 0.50 0.97 3.1% 19.9%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Pacific Biosciences of California, Inc. develops, manufactures and markets an integrated platform for genetic analysis. It has developed a technology to study the synthesis and regulation of DNA combining recent advances in nanofabrication, biochemistry, molecular biology, surface chemistry, and optics. The company has developed a technology platform called single molecule, real-time, or SMRT, technology to study the synthesis and regulation of DNA. SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events. Its initial focus is on DNA sequencing market where a third generation sequencing platform using proprietary SMRT technology, the PacBio RS. The PacBio RS a third generation sequencing instrument that provides real-time information at the single molecule level which includes instrument platform that uses its proprietary consumables, including its SMRT Cells and reagent kits, providing a complete solution to the customer. The company was founded by Stephen Turner and Joseph V. Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.